Backed by European financing, the Aussie biotech has cofounded a UK-based company to develop novel drugs.
Backed by European financing, the Aussie biotech has cofounded a UK-based company to develop novel drugs.
End of content
No more pages to load
From The Source
- GMHBA announces McCormack will build flagship medical centre in Geelong CBD
- Follow-up after major traumatic injury: a survey of services in Australian and New Zealand public hospitals
- Patient seriously harmed after equipment fails during heart surgery
- Ubiquitin trailblazer elected Fellow of prestigious Royal Society – WEHI
- RACGP: GPs celebrated on World Family Doctor Day
- AFDO: Budget Fail for Australians with Disability
- DSS: NDIS shonks put on notice
- National Health Reform public hospital funding National report – April 2024
- DoHAC: Australia’s newborn bloodspot screening programs to include new conditions
- DoHAC: $10 million for research to address areas of unmet health need using existing data infrastructure in new ways
- Breaking the silence on miscarriage
- NSW Health: First designs unveiled for new Wyong Palliative Care Unit